212 related articles for article (PubMed ID: 10793182)
1. The potential anti-addictive agent, 18-methoxycoronaridine, blocks the sensitized locomotor and dopamine responses produced by repeated morphine treatment.
Szumlinski KK; Maisonneuve IM; Glick SD
Brain Res; 2000 May; 864(1):13-23. PubMed ID: 10793182
[TBL] [Abstract][Full Text] [Related]
2. 18-MC acts in the medial habenula and interpeduncular nucleus to attenuate dopamine sensitization to morphine in the nucleus accumbens.
Taraschenko OD; Shulan JM; Maisonneuve IM; Glick SD
Synapse; 2007 Jul; 61(7):547-60. PubMed ID: 17447255
[TBL] [Abstract][Full Text] [Related]
3. Interactions between 18-methoxycoronaridine (18-MC) and cocaine: dissociation of behavioural and neurochemical sensitization.
Szumlinski KK; McCafferty CA; Maisonneuve IM; Glick SD
Brain Res; 2000 Jul; 871(2):245-58. PubMed ID: 10899291
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of the reinforcing efficacy of morphine by 18-methoxycoronaridine.
Maisonneuve IM; Glick SD
Eur J Pharmacol; 1999 Oct; 383(1):15-21. PubMed ID: 10556676
[TBL] [Abstract][Full Text] [Related]
5. 18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats.
Glick SD; Kuehne ME; Maisonneuve IM; Bandarage UK; Molinari HH
Brain Res; 1996 May; 719(1-2):29-35. PubMed ID: 8782860
[TBL] [Abstract][Full Text] [Related]
6. Reciprocal changes in dopamine responsiveness in the nucleus accumbens shell and core and in the dorsal caudate-putamen in rats sensitized to morphine.
Cadoni C; Di Chiara G
Neuroscience; 1999 May; 90(2):447-55. PubMed ID: 10215150
[TBL] [Abstract][Full Text] [Related]
7. 18-Methoxycoronaridine acts in the medial habenula to attenuate behavioral and neurochemical sensitization to nicotine.
Eggan BL; McCallum SE
Behav Brain Res; 2016 Jul; 307():186-93. PubMed ID: 27059333
[TBL] [Abstract][Full Text] [Related]
8. Catharanthine Modulates Mesolimbic Dopamine Transmission and Nicotine Psychomotor Effects via Inhibition of α6-Nicotinic Receptors and Dopamine Transporters.
Williams BM; Steed ND; Woolley JT; Moedl AA; Nelson CA; Jones GC; Burris MD; Arias HR; Kim OH; Jang EY; Hone AJ; McIntosh JM; Yorgason JT; Steffensen SC
ACS Chem Neurosci; 2024 May; 15(9):1738-1754. PubMed ID: 38613458
[TBL] [Abstract][Full Text] [Related]
9. 18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action.
Glick SD; Maisonneuve IM; Szumlinski KK
Ann N Y Acad Sci; 2000 Sep; 914():369-86. PubMed ID: 11085336
[TBL] [Abstract][Full Text] [Related]
10. 18-Methoxycoronaridine acts in the medial habenula and/or interpeduncular nucleus to decrease morphine self-administration in rats.
Glick SD; Ramirez RL; Livi JM; Maisonneuve IM
Eur J Pharmacol; 2006 May; 537(1-3):94-8. PubMed ID: 16626688
[TBL] [Abstract][Full Text] [Related]
11. Dizocilpine (MK-801) and tetrodotoxin influence accumbal dopamine release evoked by intrapallidal morphine.
Anagnostakis Y; Kastellakis A; Spyraki C
Eur Neuropsychopharmacol; 1998 Feb; 8(1):47-53. PubMed ID: 9452940
[TBL] [Abstract][Full Text] [Related]
12. A single exposure to morphine induces long-lasting behavioural and neurochemical sensitization in rats.
Vanderschuren LJ; De Vries TJ; Wardeh G; Hogenboom FA; Schoffelmeer AN
Eur J Neurosci; 2001 Nov; 14(9):1533-8. PubMed ID: 11722615
[TBL] [Abstract][Full Text] [Related]
13. Effects of 18-methoxycoronaridine on acute signs of morphine withdrawal in rats.
Rho B; Glick SD
Neuroreport; 1998 May; 9(7):1283-5. PubMed ID: 9631413
[TBL] [Abstract][Full Text] [Related]
14. Acute iboga alkaloid effects on extracellular serotonin (5-HT) levels in nucleus accumbens and striatum in rats.
Wei D; Maisonneuve IM; Kuehne ME; Glick SD
Brain Res; 1998 Aug; 800(2):260-8. PubMed ID: 9685673
[TBL] [Abstract][Full Text] [Related]
15. Ethanol, like psychostimulants and morphine, causes long-lasting hyperreactivity of dopamine and acetylcholine neurons of rat nucleus accumbens: possible role in behavioural sensitization.
Nestby P; Vanderschuren LJ; De Vries TJ; Hogenboom F; Wardeh G; Mulder AH; Schoffelmeer AN
Psychopharmacology (Berl); 1997 Sep; 133(1):69-76. PubMed ID: 9335083
[TBL] [Abstract][Full Text] [Related]
16. Anti-addictive actions of an iboga alkaloid congener: a novel mechanism for a novel treatment.
Maisonneuve IM; Glick SD
Pharmacol Biochem Behav; 2003 Jun; 75(3):607-18. PubMed ID: 12895678
[TBL] [Abstract][Full Text] [Related]
17. Morphine acutely and persistently attenuates nonvesicular GABA release in rat nucleus accumbens.
Schoffelmeer AN; Wardeh G; Vanderschuren LJ
Synapse; 2001 Nov; 42(2):87-94. PubMed ID: 11574945
[TBL] [Abstract][Full Text] [Related]
18. Interactions between iboga agents and methamphetamine sensitization: studies of locomotion and stereotypy in rats.
Szumlinski KK; Balogun MY; Maisonneuve IM; Glick SD
Psychopharmacology (Berl); 2000 Aug; 151(2-3):234-41. PubMed ID: 10972470
[TBL] [Abstract][Full Text] [Related]
19. Co-administration of dextromethorphan with morphine attenuates morphine rewarding effect and related dopamine releases at the nucleus accumbens.
Huang EY; Liu TC; Tao PL
Naunyn Schmiedebergs Arch Pharmacol; 2003 Nov; 368(5):386-92. PubMed ID: 14564449
[TBL] [Abstract][Full Text] [Related]
20. Long-term opiate effects on amphetamine-induced dopamine release in the nucleus accumbens core and conditioned place preference.
He S; Li N; Grasing K
Pharmacol Biochem Behav; 2004 Feb; 77(2):327-35. PubMed ID: 14751461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
